TREE NEWS update: Moderna reported third-quarter earnings per share of $0.38, beating expectations, and raised its full-year revenue growth guidance to 15% to 25%. The company also lifted its year-end cash balance forecast to $81 billion to $83 billion while lowering its research and development expense outlook. Shares rose 0.41% in after-hours trading following the release.
Moderna Q3 EPS $0.38, raises full-year revenue growth guidance to 15%-25%
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
6m ago
SoftBank Group Shares Jump More Than 11%
14m ago
Korea Exchange Triggers Sidecar, Halts KOSDAQ Program Buying
22m ago
Seoul Composite Opens Up 5%; Nikkei 225 Rises 2.4%
24m ago
MSCI Asia-Pacific Index Rises 1.1% to 252.49
26m ago
Nikkei 225 opens up 0.9%, Kospi jumps 4.6%
39m ago
WuXi AppTec Says Pentagon Removes It From 1260H CMC List